Agentix Corp
Agentix Corp., a clinical development stage company, focuses on the development and commercialization of novel therapeutics to treat metabolic diseases in the United States. It develops AGTX-2004, a peripherally-acting CB1 receptor antagonist that has demonstrated efficacy in animal models of obesity and type 2 diabetes mellitus; and AGTX-2003, a peripherally-acting CB1 receptor inverse agonist, … Read more
Market Cap & Net Worth: Agentix Corp (AGTX)
Agentix Corp (PINK:AGTX) has a market capitalization of $2.05 Million ($2.05 Million) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #34947 globally and #11395 in its home market, demonstrating a -36.13% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Agentix Corp's stock price $0.05 by its total outstanding shares 40066951 (40.07 Million).
Agentix Corp Market Cap History: 2016 to 2025
Agentix Corp's market capitalization history from 2016 to 2025. Data shows change from $12.22 Million to $2.05 Million (-15.10% CAGR).
Agentix Corp Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Agentix Corp's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
5476.89x
Agentix Corp's market cap is 5476.89 times its annual revenue
1728.56x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $12.22 Million | $43.14K | -$298.84K | 283.25x | N/A |
| 2018 | $4.21 Million | $2.25K | -$414.87K | 1869.79x | N/A |
| 2021 | $20.03 Million | $1.24K | -$383.43K | 16156.03x | N/A |
| 2022 | $6.79 Million | $1.24K | -$1.34 Million | 5476.89x | N/A |
Competitor Companies of AGTX by Market Capitalization
Companies near Agentix Corp in the global market cap rankings as of March 19, 2026.
Key companies related to Agentix Corp by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Agentix Corp Historical Marketcap From 2016 to 2025
Between 2016 and today, Agentix Corp's market cap moved from $12.22 Million to $ 2.05 Million, with a yearly change of -15.10%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $2.05 Million | -78.71% |
| 2024 | $9.62 Million | +674.19% |
| 2023 | $1.24 Million | -81.71% |
| 2022 | $6.79 Million | -66.10% |
| 2021 | $20.03 Million | 0.00% |
| 2020 | $20.03 Million | +108.33% |
| 2019 | $9.62 Million | +128.57% |
| 2018 | $4.21 Million | -65.57% |
| 2017 | $12.22 Million | 0.00% |
| 2016 | $12.22 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Agentix Corp was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.05 Million USD |
| MoneyControl | $2.05 Million USD |
| MarketWatch | $2.05 Million USD |
| marketcap.company | $2.05 Million USD |
| Reuters | $2.05 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.